CouncilMR. Streptomycin treatment of pulmonary tuberculosis. BMJ1948;2:769.
2.
BoneRC, FisherCJJr, ClemmerTP, SlotmanGJ, MetzCA, BalkRA. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med1987;317(11):653–658.
3.
RuffinJM, GrizzleJE, HightowerNC, McHardyG, ShullH, KirsnerJB. A co-operative double-blind evaluation of gastric "freezing" in the treatment of duodenal ulcer. N Engl J Med1969;281(1):16–19.
4.
MeinertCL, TonasciaS.Clinical trials: design, conduct, and anal-ysis. New York: Oxford University Press; 1986.
5.
HulleySB, CummingsSR. Designing clinical research: an epi-demiologic approach. Baltimore: Williams & Wilkins; 1988.
6.
SackettDL. Bias in analytic research. J Chronic Dis1979;32(1-2):51–63.
7.
SacksH, ChalmersTC, SmithHJr. Randomized versus historical controls for clinical trials. Am J Med1982;72(2):233–240.
8.
SacksHS, ChalmersTC, SmithHJr. Sensitivity and specificity of clinical trials. Randomized v historical controls. Arch Intern Med1983;143(4):753–755.
9.
SheinerLB, RubinDB. Intention-to-treat analysis and the goals of clinical trials. Clin Pharmacol Ther1995;57(1):6–15.
10.
SennSJ. Covariate imbalance and random allocation in clinical trials. Stat Med1989;8(4):467–475.
11.
BrennanP, CroftP.Interpreting the results of observational research: chance is not such a fine thing. BMJ1994;309(6956):727–730.
12.
GreenlandS.Randomization, statistics, and causal inference. Epi-demiology. 1990;1(6):421–429.
13.
FreimanJA, ChalmersTC, SmithHJr, KueblerRR. The importance of beta, the type II error and sample size in the design and inter-pretation of the randomized control trial. Survey of 71 "negative" trials. N Engl J Med1978;299(13):690–694.
14.
Le GallJR, LemeshowS, LeleuG, KlarJ, HilliardJ, RueM, . Customized probability models for early severe sepsis in adult in-tensive care patients. Intensive Care Unit Scoring Group. JAMA1995;273(8):644–650.
15.
KnausWA, HarrellFEJr, WagnerDP, OpalSM, Drap-erEA, . The clinical evaluation of new drugs for sepsis. A prospec-tive study design based on survival analysis. JAMA1993;270(10):1233–1241.
16.
RobinsonLD, JewellNP. Some surprising results about covariate adjustment in logistic regression models. International Statistical Re-view. 1991;59:227–240.
17.
ShapiroSH, LouisTA. Clinical trials: issues and approaches. New York: M Dekker; 1983.
18.
EnasGG, EnasNH, SpradlinCT, WilsonMG, WiltseCG. Baseline comparability in clinical trials: prevention of "poststudy anxiety."Drug Information Journal. 1990;24:541–548.
19.
ByarDP, PiantadosiS.Factorial designs for randomized clinical trials. Cancer Treat Rep1985;69(10):1055–1063.
20.
BeggCB. Suspended judgment. Significance tests of covariate im-balance in clinical trials. Control Clin Trials1990;11(4):223–225.
21.
Aspirin-Myocardial Infarction Study Research Group. A random-ized, controlled trial of aspirin in persons recovered from myo-cardial infarction. JAMA1980;243(7):661–669.
22.
FeinsteinAR. Current problems and future challenges in random-ized clinical trials. Circulation1984;70(5):767–774.
23.
BeecherHK. Ethics and clinical research. N Engl J Med1966;274(24):1354–1360.
24.
FreedmanB.Equipoise and the ethics of clinical research. N Engl J Med1987;317(3):141–145.
25.
WachterRM. AIDs, activism, and the politics of health. N Engl J Med. 1992;326(2):128–133.
26.
PetoR, CollinsR, GrayR.Large-scale randomized evidence: large, simple trials and overviews of trials. J Clin Epidemiol1995;48(1):23–40.
LauJ, AntmanEM, Jimenez-SilvaJ, KupelnickB, MostellerF, ChalmersTC. Cumulative meta-analysis of therapeutic trials for my-ocardial infarction. N Engl J Med1992;327(4):248–254.
29.
RobinsJM, GreenlandS.The role of model selection in causal in-ference from nonexperimental data. Am J Epidemiol1986;123(3):392–402.
30.
HolmbergL, SteineckG.Indication for treatment can introduce bias in observational studies of surgical treatment (editorial). Eur J Surg Oncol1993;19(3):223–225.
31.
HlatkyMA, CaliffRM, HarrellFEJr, LeeKL, MarkDB, PryorDB. Comparison of predictions based on observational data with the re-sults of randomized controlled clinical trials of coronary artery by-pass surgery. J Am Coll Cardiol1988;11(2):237–245.
32.
HammermeisterKE, DeRouenTA, MurrayJA, DodgeHT. Effect of aortocoronary saphenous vein bypass grafting on death and sud-den death. Comparison of nonrandomized medically and surgical-ly treated cohorts with comparable coronary disease and left ven-tricular function. Am J Cardiol1977;39(6):925–934.
33.
ParadiseJL, BluestoneCD, BachmanRZ, . Efficacy of tonsil-lectomy for recurrent throat infection in severely affected children. Results of parallel randomized and nonrandomized clinical trials. N Engl J Med1984;310(11):674–683.
34.
AdamsME, McCallNT, GrayDT, OrzaMJ, ChalmersTC. Eco-nomic analysis in randomized control trials. Med Care1992;30(3):231–243.
